These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Predictive value of osteocalcin in bone metastatic differentiated thyroid carcinoma.
    Author: Gao Y, Lu H, Luo Q, Wu X, Sheng S.
    Journal: Clin Biochem; 2010 Feb; 43(3):291-5. PubMed ID: 19732762.
    Abstract:
    OBJECTIVES: To evaluate the diagnostic value of serum osteocalcin in the detection of bone metastases from differentiated thyroid carcinoma (DTC). DESIGN AND METHODS: Serum samples from DTC patients with (DTC BM+, n=19) or without bone metastases (DTC BM-, n=19), and matched healthy volunteers (n=30) were tested for serum osteocalcin with electrochemiluminescent immunoassay. RESULTS: Osteocalcin was higher in DTC BM+ than in DTC BM- patients (+35.8%, p=0.002), acting as an independent risk factor for bone metastases (R(2)=0.142, p=0.039). The sensitivity was 78.9% and the specificity was 63.2% at a cut-off value of 11.2 microg/L. CONCLUSIONS: Serial measurements of osteocalcin could be useful in the detection of bone metastases from DTC.
    [Abstract] [Full Text] [Related] [New Search]